Digest Réseau Comment ça marche
Réseau
/
Sociétés
Ch
Non vérifié

Chiesi Global Rare Diseases

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueMédecine Santé Bien-êtreSanté

8 communiqués de presse

Voir tous les communiqués de presse
04/06/2026
Biotechnologie
Médecine Santé Bien-être
Annonces Économiques
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
Source
Chiesi Global Rare Diseases
Émetteur
GLOBENEWSWIRE
1.00
0
02/06/2026
Biotechnologie
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
Source
Chiesi Global Rare Diseases
Émetteur
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotechnologie
Annonces Économiques
Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
Source
Chiesi Global Rare Diseases
Émetteur
GLOBENEWSWIRE
1.00
0
30/01/2026
Biotechnologie
Médecine Santé Bien-être
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Source
Chiesi Global Rare Diseases
Émetteur
GLOBENEWSWIRE
1.00
0
30/01/2026
Biotechnologie
Médecine Santé Bien-être
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Source
Chiesi Global Rare Diseases
Émetteur
GLOBENEWSWIRE
1.00
0
19/06/2025
Science
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
Industrie
Chiesi Global Rare Diseases assegna finanziamenti per la ricerca per promuovere l'innovazione nelle malattie lisosomiali
Source
Chiesi Global Rare Diseases
Émetteur
Business Wire
1.00
0
19/06/2025
Science
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
Industrie
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
Source
Chiesi Global Rare Diseases
Émetteur
Business Wire
1.00
0
Press Release cover image
09/09/2024
Industrie pharmaceutique
Santé Publique
Économie
Start-up
Biologie
Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders
Source
Chiesi Global Rare Diseases
Émetteur
PR News Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0